From - National Intelligence Report
A trio of recent FDA product approvals in the diagnostics space have belied the agency's traditional reputation for resisting medical innovation. Here's the timeline for…
From - Diagnostic Testing & Emerging Technologies
As the price of sequencing continues to drop and genomic testing in oncology continues to shift towards larger panels, physicians have self-reported difficulty in…